Pharmacy Practice
Affordable Medicines
Biosimilars
Compliance
Compounding
Drug Approvals
Geriatrics
Hospital/Health System
In-Pharmacy Vaccines
Law
Medication Management
News & Trends
OTC
Pharmacist Resources
Specialty Pharmacy
Technology
Disease State
Allergy
Autoimmune
Breast Cancer
Cardiovascular
Cold & Flu
COVID-19
Dermatology
Diabetes
Gastroenterology
Hematology
HIV/AIDS
Infectious Disease
Infusion
Lung Cancer
Mental Health
mRNA Technology
Neurology
Oncology
Ophthalmology
Orthopedics
Pain Management
Pediatrics
Respiratory
Schizophrenia
Urology/Nephrology
Women’s Health
Health Awareness Month
Videos
Patient Teaching Aid
Publications
Featured Issue
Featured Supplements
Conference Coverage
Continuing Education
Subscribe
COVID-19 Resources
January 2023
Digital Magazine
Archives
Subscription
Features
Community Pharmacists’ Role in the Treatment of Epilepsy
Diagnosing and Managing Neuromyelitis Optica
Neurologic Lyme Disease and the Role of the Pharmacist
Severe Drug-Induced Neurologic Disorders
Treatment Options for Gout
Departments
Clinical News Digest
Specialty Pharmacy News Digest
Consult Your Pharmacist
Managing Glaucoma
Contemporary Compounding
Lamotrigine 1 mg/mL Compounded Oral Suspension, USP
Editorial
How COVID-19 Causes Neurologic Damage
TrendWatch
Risks and Considerations for Epilepsy
X
April 2024
In This Issue
Digital Magazine
Archives
Subscription
Continuing Education
$7.95 Per CE Exam or $69 for 12 Lessons
• April 2026
• 2.00 Credits
Managing HIV Coinfections and Complications
Pain Management
• March 2026
• 2.00 Credits
Updated Guidance for Opioid Use in Pain Management
Cardiovascular
• February 2026
• 2.00 Credits
Managing Modifiable Risk Factors in Chronic Coronary Disease
×
Full Image